177 related articles for article (PubMed ID: 11402850)
1. [Pulmonary lymphangioleiomyomatosis. Morphologic and immunohistochemical findings].
Kuhnen C; Preisler K; Müller KM
Pathologe; 2001 May; 22(3):197-204. PubMed ID: 11402850
[TBL] [Abstract][Full Text] [Related]
2. Combined smooth muscle and melanocytic differentiation in lymphangioleiomyomatosis.
Zhe X; Schuger L
J Histochem Cytochem; 2004 Dec; 52(12):1537-42. PubMed ID: 15557209
[TBL] [Abstract][Full Text] [Related]
3. [Pulmonary lymphangioleiomyomatosis (LAM). Diagnostic usefulness of immunohistochemical markers].
Serrano Pardo R; Sotelo Rodríguez MT; Alvarez Martínez C; Ballestin Carcavilla C; Larrú Cabrero E
Arch Bronconeumol; 1998 Nov; 34(10):509-11. PubMed ID: 9881218
[TBL] [Abstract][Full Text] [Related]
4. Angiomyomatous hamartoma of lymph nodes, revisited: clinicopathologic study of 21 cases, emphasizing its distinction from lymphangioleiomyomatosis of lymph nodes.
Moh M; Sangoi AR; Rabban JT
Hum Pathol; 2017 Oct; 68():175-183. PubMed ID: 28899738
[TBL] [Abstract][Full Text] [Related]
5. Incidental Pelvic and Para-aortic Lymph Node Lymphangioleiomyomatosis Detected During Surgical Staging of Pelvic Cancer in Women Without Symptomatic Pulmonary Lymphangioleiomyomatosis or Tuberous Sclerosis Complex.
Rabban JT; Firetag B; Sangoi AR; Post MD; Zaloudek CJ
Am J Surg Pathol; 2015 Aug; 39(8):1015-25. PubMed ID: 25786086
[TBL] [Abstract][Full Text] [Related]
6. β-Catenin is a useful adjunct immunohistochemical marker for the diagnosis of pulmonary lymphangioleiomyomatosis.
Flavin RJ; Cook J; Fiorentino M; Bailey D; Brown M; Loda MF
Am J Clin Pathol; 2011 May; 135(5):776-82. PubMed ID: 21502434
[TBL] [Abstract][Full Text] [Related]
7. Cathepsin K is Superior to HMB45 for the Diagnosis of Pulmonary Lymphangioleiomyomatosis.
Rolim I; Makupson M; Lovrenski A; Farver C
Appl Immunohistochem Mol Morphol; 2022 Feb; 30(2):108-112. PubMed ID: 34433182
[TBL] [Abstract][Full Text] [Related]
8. Retroperitoneal lymphangioleiomyoma with lymph node involvement: A pathologic-radiologic correlation of a rare form of myomelanocytic tumor.
Abdelkader A; Lam CA; Shahir KS; Christians K; Suster SM
Ann Diagn Pathol; 2017 Apr; 27():69-73. PubMed ID: 28325364
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical evaluation of pulmonary lymphangioleiomyomatosis.
Grzegorek I; Lenze D; Chabowski M; Janczak D; Szolkowska M; Langfort R; Szuba A; Dziegiel P
Anticancer Res; 2015 Jun; 35(6):3353-60. PubMed ID: 26026095
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of estrogen and progesterone receptors in the abnormal smooth muscle cells in pulmonary lymphangioleiomyomatosis following therapy. An immunohistochemical study.
Matsui K; Takeda K; Yu ZX; Valencia J; Travis WD; Moss J; Ferrans VJ
Am J Respir Crit Care Med; 2000 Mar; 161(3 Pt 1):1002-9. PubMed ID: 10712355
[TBL] [Abstract][Full Text] [Related]
11. Matrix proteoglycans and remodelling of interstitial lung tissue in lymphangioleiomyomatosis.
Merrilees MJ; Hankin EJ; Black JL; Beaumont B
J Pathol; 2004 Jun; 203(2):653-60. PubMed ID: 15141380
[TBL] [Abstract][Full Text] [Related]
12. Lymphangioleiomyomatosis (LAM): a review of clinical and morphological features.
Ferrans VJ; Yu ZX; Nelson WK; Valencia JC; Tatsuguchi A; Avila NA; Riemenschn W; Matsui K; Travis WD; Moss J
J Nippon Med Sch; 2000 Oct; 67(5):311-29. PubMed ID: 11031360
[TBL] [Abstract][Full Text] [Related]
13. Expression of human telomerase reverse transcriptase in lymphangioleiomyomatosis.
Kumaki F; Takeda K; Yu ZX; Moss J; Ferrans VJ
Am J Respir Crit Care Med; 2002 Jul; 166(2):187-91. PubMed ID: 12119231
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the use of antibodies to alpha smooth muscle actin and desmin in pulmonary lymphangioleiomyomatosis.
Matthews TJ; Hornall D; Sheppard MN
J Clin Pathol; 1993 May; 46(5):479-80. PubMed ID: 8320334
[TBL] [Abstract][Full Text] [Related]
15. Incidental Nodal Lymphangioleiomyomatosis Is Not a Harbinger of Pulmonary Lymphangioleiomyomatosis: A Study of 19 Cases With Evaluation of Diagnostic Immunohistochemistry.
Schoolmeester JK; Park KJ
Am J Surg Pathol; 2015 Oct; 39(10):1404-10. PubMed ID: 26135558
[TBL] [Abstract][Full Text] [Related]
16. [Pulmonary lymphangioleiomyomatosis].
Dvorakovskaia IV; Baranova OP
Arkh Patol; 2005; 67(5):29-32. PubMed ID: 16323477
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-beta 1 and extracellular matrix-associated fibronectin expression in pulmonary lymphangioleiomyomatosis.
Evans SE; Colby TV; Ryu JH; Limper AH
Chest; 2004 Mar; 125(3):1063-70. PubMed ID: 15006970
[TBL] [Abstract][Full Text] [Related]
18. Immunohistological features related to functional impairment in lymphangioleiomyomatosis.
Nascimento ECTD; Baldi BG; Mariani AW; Annoni R; Kairalla RA; Pimenta SP; da Silva LFF; Carvalho CRR; Dolhnikoff M
Respir Res; 2018 May; 19(1):83. PubMed ID: 29739412
[TBL] [Abstract][Full Text] [Related]
19. Tuberous sclerosis complex presenting as a pulmonary solitary nodule.
Rossi G; Cavazza A; Casali C; Cesinaro AM; Cinquantini F; Morandi U
Histopathology; 2006 May; 48(6):769-71. PubMed ID: 16681699
[No Abstract] [Full Text] [Related]
20. Antibody αPEP13h reacts with lymphangioleiomyomatosis cells in lung nodules.
Valencia JC; Steagall WK; Zhang Y; Fetsch P; Abati A; Tsukada K; Billings E; Hearing VJ; Yu ZX; Pacheco-Rodriguez G; Moss J
Chest; 2015 Mar; 147(3):771-777. PubMed ID: 25411763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
